• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Febuxostat

Febuxostat

Product ID F1607
Cas No. 144060-53-7
Purity ≥98%
Product Unit SizeCostQuantityStock
50 mg $54.60 In stock
250 mg $107.80 In stock
1 g $287.20 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Febuxostat displays a variety of beneficial properties, including anti-inflammatory, anti-hyperuricemic, antidepressant, and nephroprotective activities. Febuxostat inhibits xanthine oxidase, preventing the generation of uric acid; as a result, it is used clinically to treat gout. In vitro, febuxostat inhibits MCP-1 and ROS production through activation of MAPK phosphatase. In vivo, febuxostat decreases oxidative stress and endoplasmic reticular stress, preventing increases in serum creatine and occurrence of renal tubular injury and fibrosis during renal ischemia. Additionally, this compound decreased immobility time during a forced swim test in animal models of depression.

Product Info

Cas No.

144060-53-7

Purity

≥98%

Formula

C16H16N2O3S

Formula Wt.

316.37

Chemical Name

2-(3-cyano-4-isobutoxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid

IUPAC Name

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

F1607 MSDS PDF

Info Sheet

F1607 Info Sheet PDF

References

Nomura J, Busso N, Ives A, et al. Febuxostat, an Inhibitor of Xanthine Oxidase, Suppresses Lipopolysaccharide-Induced MCP-1 Production via MAPK Phosphatase-1-Mediated Inactivation of JNK. PLoS One. 2013 Sep 25;8(9):e75527. PMID: 24086554.

Karve AV, Jagtiani SS, Chitnis KA. Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice. Indian J Pharmacol. 2013 May-Jun;45(3):244-7. PMID: 23833366.

Tsuda H, Kawada N, Kaimori JY, et al. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress. Biochem Biophys Res Commun. 2012 Oct 19;427(2):266-72. PMID: 22995295.

Bisht M, Bist SS. Febuxostat: a novel agent for management of hyperuricemia in gout. Indian J Pharm Sci. 2011 Nov;73(6):597-600. PMID: 23112391.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • S8013

    [Tyr8]-Substance P

    Endogenous tachykinin peptide, involved in infl...

    ≥95%
  • H9718

    2-Hydroxyflutamide

    Non-steroid; AR antagonist.

    ≥98%
  • U6802

    Urapidil Hydrochloride

    5-HT1A agonist, α1-adrenergic antagonist.

    ≥98%
  • S8251

    Sulfluramid

    Perfluorinated insecticide.

    ≥95%
  • C0221

    Caffeine

    Xanthine alkaloid found in coffee, tea, and oth...

    ≥98%
  • A9978

    Aztreonam

    β-lactam; penicillin binding protein inhibitor...

    ≥96%
  • B3210

    R-Bicalutamide

    AR antagonist.

    ≥98%
  • E544766

    Enterocin

    A bacteriocin

    ≥95%
  • C6019

    C-Peptide, human

    Endogenous peptide, connects A and B chains of ...

    ≥95%
  • N8663

    NVP-LDE225 Diphosphate

    Smo inhibitor.

    ≥98%
  • G4532

    Gliclazide

    Sulfonylurea; SUR1 antagonist.

    ≥98%
  • P1845

    Pelitinib

    EGFR inhibitor.

    ≥98%
  • C2845

    Levo-Chloramphenicol

    Protein translation inhibitor, peptidyl transfe...

    ≥98%
  • P7012

    Prednisolone Sodium Phosphate

    Water-soluble cortisol derivative; glucocortico...

    ≥98%
  • M568268

    Mogroside IV

    Triterpenoid

    ≥98%
  • F5773

    Fosinopril Sodium

    ACE inhibitor.

    ≥98%
  • F8147

    Fulvestrant

    Induces ER degradation.

    ≥98%
  • M0278

    Matrine

    Alkaloid found in Sophora.

    ≥98%
  • U482046

    (-)-Umbellulone

    Antimicrobial found in essential oils from plan...

    ≥98%
  • D5992

    Doxapram Hydrochloride Hydrate

    K+ channel blocker, catecholamine release stimu...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only